Article info

Download PDFPDF

Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis
  1. Désirée van der Heijde, Korte Raarberg 46, 6231 KR Meerssen, The Netherlands; d.vanderheijde{at}kpnplanet.nl
View Full Text

Citation

van der Heijde D, Pangan AL, Schiff MH, et al
Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis

Publication history

  • Accepted November 18, 2007
  • First published December 4, 2007.
Online issue publication 
August 12, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.